0% found this document useful (0 votes)
10 views31 pages

DR Adeel

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1/ 31

Anesthesia considerations specific to

orthopedic surgery (BCIS,FES)

Prepared and presented by: Dr Muhammad Adeel Khalid


Bone cement implantation syndrome

INTRODUCTION:
 BCIS is a potentially fatal complication of orthopedic surgery, involving
pressurized bone cement.
 characterized by hypoxia and hypotension (with potential loss of consciousness),
occurring around the time of bone cementation.
 the incidence of a severe reaction may result in cardiovascular collapse.
 20% of cemented hemiarthroplasties have BCIS, with around 1% of these
resulting in cardiovascular collapse requiring CPR.
What is bone cement

 It is a radio-opaque compound composed of polymethyl methacrylate) (90%) and


a small quantity of radio-opaque crystals
 Polymethylmethacrylate (PMMA) is a sterile acrylic polymer usually supplied as
two component systems made up of a fine powder and a liquid.
 These two components are mixed to start a chemical reaction called
polymerization, which forms the polymethylmethacrylate (PMMA) cement.
 The two components are mixed and the bone cement viscosity changes over time
from a runny liquid into a dough like state (2-3 minutes) that can be safely applied
(5-8 minutes) and then finally hardens into solid hardened material.
Proposed definition of bone cement
implantation syndrome:
No agreed standard definition.
Donaldson and colleagues* have proposed a standard definition of BCIS:
 “BCIS is characterized by hypoxia, hypotension or both and/or unexpected loss of
consciousness occurring around the time of cementation, prosthesis insertion,
reduction of the joint or, occasionally, limb tourniquet deflation in a patient
undergoing cemented bone surgery.”
Clinical features:

 It results in reduced arterial oxygenation, characterized by a combination of


clinical features:
• Hypoxia
• Sudden loss of arterial pressure
• Pulmonary hypertension
• Arrhythmias
• Loss of consciousness
• Cardiac arrest
Classification and incidence:
Classification is based on the degree of hypoxia, hypotension and conscious level, as per Donaldson.

BCIS Grade Hypoxia Hypotension Loss of Incidence


Consciousn
ess
Grade 1 Moderate: Moderate: Decrease in SBP ≥ None 21%
SpO2 20%
<94%
Grade 2 Severe: Severe: Decrease in SBP ≥ 40% Unexpected 5.1%
SpO2 loss of
<88% consciousne
ss
Grade 3 Cardiovascular collapse 1.7%
requiring CPR
Risk factors for the development of BCIS:

Patient factors: Surgical factors:

 ASA III–IV  Pathological fracture


 Pre-existing pulmonary hypertension  Intertrochanteric fracture
 Significant cardiac disease  Long-stem arthroplasty
 Osteoporosis
 Male sex
 Increasing age
The causes of BCIS:

 There is no proven cause of BCIS but several theories exist. The most commonly accepted
cause is the embolic model.
Embolic model:
 During surgical cementation and prosthesis insertion, the cement is intentionally
pressurized to force into the small gaps/spaces of the bone, improving bonding between the
cement and bone.
 cement then expands in the space between the bone and the prosthesis, further pressurizing
air and the bone contents into the circulation.
 These debris may reach the lungs, heart or coronary circulation.
 pulmonary emboli are the cause of the characteristic hypoxia and right ventricular
dysfunction leading to hypotension.
Other causes:

 The direct effect of the exothermic reaction of cement temperature


 Air or gas embolism caused by polymerisation of methyl methacrylate monomer.
 Hypersensitivity/anaphylactic reaction to the monomer.
The effect of anesthetic technique on the severity
of BCIS:
 The general principles of management include the maintenance of normovolaemia
to avoid the cardiovascular consequences of cementing and the maintenance of
high inspired concentrations of oxygen.
 use of high anesthetic vapor concentrations should be avoided as it is associated
with greater hemodynamic compromise.
 The use of intraop CO monitoring has been recommended in patients with one or
more risk factors for BCIS. It can be in the form of semi-invasive
transoesophageal Doppler monitor or invasive CO monitor like PA catheter.
Role of surgery in prevention of bone cement-
associated complications
Surgical measures that can reduce the incidence of complications associated with
bone cement, especially BCIS, include:
• thorough lavage of the femoral canal to remove debris.
• Brushing and drying of the intramedullary canal of the femoral shaft before
cementation
• Use of a suction catheter to depressurize the intramedullary canal
• Utilizing a bone-vacuum technique (mixing cement in a vacuum and using a
retrograde cement introduction)
• the use of non-cemented prostheses in high risk patients.
Key intraoperative roles for managing
potential BCIS
Anesthetic team Surgical team
Ensure adequate hemodynamic optimisation pre- and intra- Inform the anaesthetist prior to cement application
operatively
Aim for a SBP within 20% of pre-induction value Wash and dry the femoral canal
Prepare vasopressors in case of cardiovascular collapse Apply cement retrograde, utilising a suction catheter and
intramedullary plug in the femoral shaft

Confirm awareness that cement is about to be prepared/applied Avoid excessive pressurisation

Maintain vigilance for cardiorespiratory compromise


Cement Curfew:

 A ‘Cement Curfew’ protocol has been adopted at some institutions, which


involves all members of the operating theatre team assuming specific roles and
focus around the time of prosthesis insertion.
 important steps during the process are formally verbalized by the lead surgeon
including the start and end of the curfew.
The management of BCIS

 BCIS is a reversible time-limited phenomenon recovery time ranges from few


seconds to 24 hours.
 The patient’s chance of survival is increased if immediate recognized and
supportive measures are rapidly initiated.
 aggressive resuscitation and supportive treatment is essential to reduce the
morbidity and mortality of this life-threatening situation.
 A fall in end tidal carbon dioxide concentration may be the first indication of
BCIS in the anaesthetized patient and should alert the anesthetist.
 Early signs of BCIS in an awake patient undergoing regional anesthesia include
dyspnea and ALOC
The management of BCIS

 Grade 1 BCIS can be treated with increased increasing the oxygen to 100%,
fluids and vasopressors if needed.
 In cases of severe BCIS (when the patient has arrested, or in a peri-arrest
condition), standard (ACLS) algorithms and procedures should be followed.
 Fluid resuscitation to maintain right ventricle preload, and inotropes to support
ventricular contractility are recommended.
 Vasopressors (such as phenylephrine and noradrenaline) can be used as they
primarily cause peripheral vasoconstriction, increase aortic blood pressure, which
in turn supports coronary artery blood flow, and thus improve myocardial
perfusion and contractility.
 Use of vasopressors and inotropes should be continued into the postoperative
period as necessary, under the management of the intensive care unit (ICU).
The AAGBI guideline recommendations
Delivery of 100% oxygen
Fluid resuscitation (guided by CVP measurement)
Vasoactive ⁄ inotropic support

SUMMARY:
• BCIS is a potentially fatal complication of orthopaedic surgery.
• Pulmonary embolisation from intramedullary contents is the likely aetiology of BCIS.
• Rapid hypoxia, hypotension and loss of consciousness are the key signs. • Good
management of BCIS includes: patient risk stratification, intraoperative vigilance, good
team communication, and prompt resuscitation.
FAT EMBOLISM SYNDROME:
Clinical manifestations:
 FES typically presents 12 to 72 hours after the initial insult.
 The classic triad of FES includes hypoxemia, neurological abnormalities, and
petechial rash.
 Pulmonary manifestations are the most common initial signs of FES which
include dyspnea, tachypnea, hypoxemia, and respiratory failure.
 Neurological defects typically manifest after the respiratory changes and include
focal deficits, confusion, lethargy, restlessness, coma.
 The petechial rash is classically located in nondependent regions (conjunctivae,
head, neck, anterior thorax, or axillae).
Other nonspecific findings:
Systemic Fever
Cardiovascular Tachycardia
Hypotension
Intraoperative arrhythmias
Myocardial ischemia
Pulmonary hypertension (PH)
Right-sided heart failure
Ophthalmic Purtscher’s retinopathy (cotton wool exudates, macular edema and hemorrhage)

Renal Oliguria
Proteinuria
Lapiduria
Hematuria
Hepatic Jaundice
Hematological Perioperative anemia
Thrombocytopenia
Coagulopathy
Fat macroglobulinemia.
Causes:
Pathophysiology of FES:

 Exact pathophysiology of FES remains unclear.


 Two theories have been proposed regarding the causes of FES
1. Mechanical theory
2. Biochemical theory
Mechanical theory:

 Obstruction of vessels and capillaries


• Increase in intramedullary pressure forces fat and marrow into bloodstream
• Bone marrow contents enter the venous system and lodge in the lungs as emboli
• Smaller fat droplets may travel through the pulmonary capillaries into the
systemic circulation.
• Embolization to cerebral vessels or renal vessels also leads to central nervous
system and renal dysfunction
Biochemical theory:

 Toxicity of free fatty acids


• circulating free fatty acids directly affect the pneumocytes, producing
abnormalities in gas exchange
• Coexisting shock, hypovolemia and sepsis impair liver function and augment
toxic effects of free fatty acids
Diagnosis:

 Differential diagnosis include pulmonary or cement emboli, vasculitic disorders,


bacterial pneumonia, sepsis, and ARDS.
 FES is a clinical diagnosis.
 Two classification schemes may be used for diagnosis.
1. Gurd’s criteria
2. Schonfeld FES Index
Gurd’s criteria:
Schonfeld FES Index:
Laboratory Studies:

 Arterial Blood Gases (ABGs): Hypoxemia (PaO2 <60mmhg


 Hematological Tests: Anemia, thrombocytopenia, high ESR.
 Biochemical tests: LFTs, Renal profile, Serum electrolytes
 Urine and sputum examination: may detect fat globules(non specific)
Diagnostic Imaging:
 Imaging can help to confirm fat embolism or rule out alternative diagnosis.
 Chest CT is superior for diagnosing pulmonary fat emboli and may show ground-glass
appearance.
 Chest x-ray may show diffuse bilateral pulmonary infiltrates.
 Brain MRI( preferred imaging modality)should be considered in patients with neurologic
symptoms. Diffusion-weighted MRI can reveal a classic “star field” pattern of fat micro
embolism within one hour of symptoms onset. Several hours later, foci of vasogenic edema in an
embolic distribution can be seen on T2-weighted MRI.
 CT head is usually normal but could show diffuse white-matter petechial hemorrhages.
 Trans esophageal or transthoracic echocardiogram may show fat emboli as dense echogenic
material.
Management:

 Respiratory support: intubation/ventilation, indications for respiratory support:


• Sustained SaO2 <90% and PaO2 <8 kPa on oxygen
• Respiratory rate of >35 breaths/min
 Hemodynamic support:
• Maintain a systolic blood pressure > 90 mmHg
• Avoid hypovolemia with fluid resuscitation and vasopressors
• Apply invasive monitoring
• TEE
 Early surgical stabilization of fractures
 Perform operative correction rather than traction alone
 Limit the intraosseous pressure during an orthopedic procedure
Pharmacological treatment:

 Corticosteroids may reduce the risk of a fat embolism in patients with long bone
fractures of the lower limbs
 Heparin clears lipemic serum by stimulating lipase activity, thereby reducing
pulmonary complications
 Albumin use is considered potentially therapeutic in its ability to bind free fatty
acids
THANK YOU
.

You might also like